These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 15094227)

  • 1. Promoter hypermethylation-related reduced somatostatin production promotes uncontrolled cell proliferation in colorectal cancer.
    Leiszter K; Sipos F; Galamb O; Krenács T; Veres G; Wichmann B; Fűri I; Kalmár A; Patai ÁV; Tóth K; Valcz G; Tulassay Z; Molnár B
    PLoS One; 2015; 10(2):e0118332. PubMed ID: 25723531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptomic analysis identifies the neuropeptide cortistatin (CORT) as an inhibitor of temozolomide (TMZ) resistance by suppressing the NF-κB-MGMT signaling axis in human glioma.
    He Z; Peng B; Wang Q; Tian J; Liu P; Feng J; Liao Y; Chen L; Jia P; Tang J
    Genes Dis; 2024 May; 11(3):100977. PubMed ID: 38292193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin and Somatostatin Receptors in Tumour Biology.
    Kumar U
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of SLC39A6 in the development and progression of liver cancer.
    Wan Z; Wang X
    Oncol Lett; 2022 Mar; 23(3):77. PubMed ID: 35111246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targets.
    Kaemmerer D; Schindler R; Mußbach F; Dahmen U; Altendorf-Hofmann A; Dirsch O; Sänger J; Schulz S; Lupp A
    BMC Cancer; 2017 Dec; 17(1):896. PubMed ID: 29282035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Octreotide-periplocymarin conjugate prodrug for improving targetability and anti-tumor efficiency: synthesis, in vitro and in vivo evaluation.
    Zhang HY; Xu WQ; Zheng YY; Omari-Siaw E; Zhu Y; Cao X; Tong SS; Yu JN; Xu XM
    Oncotarget; 2016 Dec; 7(52):86326-86338. PubMed ID: 27861145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of octreotide and insulin on colon cancer cellular proliferation and correlation with hTERT activity.
    Ayiomamitis GD; Notas G; Zaravinos A; Drygiannakis I; Georgiadou M; Sfakianaki O; Mastrodimou N; Thermos K; Kouroumalis E
    Oncoscience; 2014; 1(6):457-67. PubMed ID: 25594044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The GH-IGF-SST system in hepatocellular carcinoma: biological and molecular pathogenetic mechanisms and therapeutic targets.
    Pivonello C; De Martino MC; Negri M; Cuomo G; Cariati F; Izzo F; Colao A; Pivonello R
    Infect Agent Cancer; 2014; 9():27. PubMed ID: 25225571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. δ-opioid receptor and somatostatin receptor-4 heterodimerization: possible implications in modulation of pain associated signaling.
    Somvanshi RK; Kumar U
    PLoS One; 2014; 9(1):e85193. PubMed ID: 24416361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical response to Auron Misheil Therapy in a man with advanced multifocal hepatocellular carcinoma: A case report.
    Scheele JS; Harder J; Stankovic Z; Räpple D; Dorn A; Spangenberg HC; Blum HE
    J Med Case Rep; 2011 Sep; 5():478. PubMed ID: 21943068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Octreotide induces caspase activation and apoptosis in human hepatoma HepG2 cells.
    Tsagarakis NJ; Drygiannakis I; Batistakis AG; Kolios G; Kouroumalis EA
    World J Gastroenterol; 2011 Jan; 17(3):313-21. PubMed ID: 21253389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of somatostatin and somatostatin receptor subtypes 1-5 in human normal and diseased kidney.
    Bhandari S; Watson N; Long E; Sharpe S; Zhong W; Xu SZ; Atkin SL
    J Histochem Cytochem; 2008 Aug; 56(8):733-43. PubMed ID: 18443363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of action and resistance of somatostatin analogues for the treatment of hepatocellular carcinoma: a message not well taken.
    Samonakis DN; Notas G; Christodoulakis N; Kouroumalis EA
    Dig Dis Sci; 2008 Sep; 53(9):2359-65. PubMed ID: 18273705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long acting octreotide in the treatment of advanced hepatocellular cancer and overexpression of somatostatin receptors: randomized placebo-controlled trial.
    Dimitroulopoulos D; Xinopoulos D; Tsamakidis K; Zisimopoulos A; Andriotis E; Panagiotakos D; Fotopoulou A; Chrysohoou C; Bazinis A; Daskalopoulou D; Paraskevas E
    World J Gastroenterol; 2007 Jun; 13(23):3164-70. PubMed ID: 17589893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortistatin production by HepG2 human hepatocellular carcinoma cell line and distribution of somatostatin receptors.
    Notas G; Kolios G; Mastrodimou N; Kampa M; Vasilaki A; Xidakis C; Castanas E; Thermos K; Kouroumalis E
    J Hepatol; 2004 May; 40(5):792-8. PubMed ID: 15094227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RT-PCR and immunocytochemistry studies support the presence of somatostatin, cortistatin and somatostatin receptor subtypes in rat Kupffer cells.
    Xidakis C; Mastrodimou N; Notas G; Renieri E; Kolios G; Kouroumalis E; Thermos K
    Regul Pept; 2007 Oct; 143(1-3):76-82. PubMed ID: 17481746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Octreotide inhibits proliferation and induces apoptosis of hepatocellular carcinoma cells.
    Liu HL; Huo L; Wang L
    Acta Pharmacol Sin; 2004 Oct; 25(10):1380-6. PubMed ID: 15456543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of human dopamine D2 and somatostatin receptor subtype expression by glucocorticoids in vitro.
    de Bruin C; Feelders RA; Waaijers AM; van Koetsveld PM; Sprij-Mooij DM; Lamberts SW; Hofland LJ
    J Mol Endocrinol; 2009 Jan; 42(1):47-56. PubMed ID: 18852217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Truncated somatostatin receptors as new players in somatostatin-cortistatin pathophysiology.
    Córdoba-Chacón J; Gahete MD; Durán-Prado M; Luque RM; Castaño JP
    Ann N Y Acad Sci; 2011 Mar; 1220():6-15. PubMed ID: 21388399
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.